The addivosome: A pathological condensate underlying addiction.

Area of Science:

• Neuroscience
• Cell Biology
• Biochemistry

Background:

• Addiction is commonly viewed as a disorder of synaptic plasticity and neural circuit rewiring.
• A cellular mechanism involving pathological changes in the postsynaptic density (PSD) is proposed as a complementary explanation for persistent relapse vulnerability.

Purpose of the Study:

• To propose and evaluate a novel cellular model where addiction vulnerability arises from a maladaptive biomolecular condensate, termed the "Addivosome."
• To investigate how repeated cycles of drug exposure, withdrawal, and abstinence contribute to the pathological maturation of the PSD into a rigid, self-maintaining state.

Main Methods:

• Utilizing proximity labeling to define proteomic and post-translational signatures of the Addivosome state.
• Employing optogenetic tools to establish causality between synaptic protein clustering/dispersal and addiction-related cellular changes.
• Screening compounds for their ability to restore molecular mobility (reliquefaction) within the PSD using fluorescence recovery after photobleaching.
• Developing autophagy-tethering chimeras for selective clearance of drug-induced signatures within the pathological condensate.

Main Results:

• Drug exposure progressively shifts the PSD towards a rigid, self-maintaining state, enforcing aberrant pathway cross-talk and biased gene regulation.
• This pathological state creates a durable cellular mnemonic resistant to dispersal, contributing to relapse vulnerability.
• The study outlines methods to discriminate pathological from physiological condensates by targeting state-specific features.

Conclusions:

• Addiction can be framed as a disorder of pathological biomolecular condensate formation (Addosomes) within the PSD.
• This model integrates synaptic biology, phase separation, and addiction neuroscience.
• Targeting the dynamics or clearance of these pathological condensates presents novel therapeutic avenues for addiction treatment.